Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Feb 15, 2011

Dutch Ministry Puts Public Vaccine Production Site up for Sale

  • The Netherlands Ministry of Health, Welfare and Sport has started the process of selling off the vaccine production facilities of its Nederlands Vaccine Institute (NVI) to the private sector. The sale results from the ministry’s 2010 decision to stop the production of vaccines through the public NVI body and integrate the institute’s other tasks into the Dutch National Institute for Public Health and the Environment (RIVM) from the beginning of this year. NVI activities that will be shifted to the RIVM include public vaccine research and development along with vaccine procurement, warehousing, and distribution.

    The NVI production facilities in Bilthoven manufacture bioipharmaceuticals including viral and bacterial vaccines. The Dutch Ministry says contract manufacturing for third parties is within the scope of activities up for sale. Current production activities at the NVI comprise: inactivated polio vaccine as bulk or final product, BCG vaccines used in the post-surgical treatment of bladder cancer, and the combined diphtheria-tetanus-polio vaccine and tetanus toxoid vaccine used for vaccinating children and adults.  



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »